Despite increasing evidence suggesting a role for NADPH oxidases (Nox) in bone pathophysiology, whether Nox enzymes contribute to obesity-mediated bone remodeling remains to be clearly elucidated. This evidence concerns the gene FMO5 and obesity due to melanocortin 4 receptor deficiency.